By elucidating the FOXQ1/SIRT1/β-catenin regulatory axis involved in CRC cell radio-resistance, the present study deepened our understanding of the mechanisms related to the radio-resistance in CRC and provided promising strategies for improving the clinical outcomes of radiotherapy for CRC patients. The gene discussed is FOXQ1; the disease is colorectal carcinoma.